Table 3.
Coefficient | SE | p value | Odds Ratio | 95% Confidence Interval of Odds Ratio |
|
---|---|---|---|---|---|
Group status (Women Only)a | −0.86 | 0.34 | 0.01 | 0.42 | 0.22—0.82 |
Propensity score | −0.02 | 0.19 | 0.91 | 0.98 | 0.68—1.41 |
Any substance use in past 30 days at baselineb | −0.06 | 0.36 | 0.87 | 1.06 | 0.52—2.15 |
Age at baseline | −0.00 | 0.01 | 0.93 | 1.00 | 0.97—1.03 |
Ethnicityc | |||||
African American | 0.02 | 0.39 | 0.96 | 1.02 | 0.48—2.18 |
Hispanic | −0.08 | 0.45 | 0.85 | 0.92 | 0.38—2.21 |
Multi/other | 0.64 | 0.54 | 0.23 | 1.91 | 0.66—5.47 |
Abused sexually before age 15d | 0.19 | 0.29 | 0.51 | 0.83 | 0.47—1.46 |
Any previous treatment at baselinee | −0.01 | 0.35 | 0.99 | 1.01 | 0.51—1.99 |
Criminal justice funding sourcef | −0.28 | 0.51 | 0.59 | 0.76 | 0.28—2.07 |
Primary Drug (Meth)g | 0.13 | 0.31 | 0.69 | 1.13 | 0.62—2.08 |
NOTE: Hosmer and Lemeshow test for goodness-of-fit, p = .27.
compared to mixed gender
compared to no use
compared to White
compared to no childhood sexual abuse
compared to no previous treatment
compared to all other funding sources
compared to other drugs